The establishment of a Diabetes and Endocrinology Research Center (DERC) at the Barbara Davis Center for Childhood Diabetes (BDC) at the University of Colorado Health Sciences Center (UCHSC) in 2000 brought together a unique group of basic and clinical scientists from different faculty and research backgrounds to enhance productivity and the quality of diabetes and endocrinology research in the university. In the five years since its foundation, basic research grant income of the DERC research base has increased two-fold to $6.4 million and clinical research income six-fold to $4.9 million mainly from NIH sources. New Program Project and Consortium funding has been developed in most areas of the Research Base including islet developmental biology, human islet transplantation, autoimmunity and diabetes translational research. In 2005 most UCHSC departments will move to the new Fitzsimons campus and the BDC will build a new Center of 110,000 sq. ft., more than three times large than the current building. This competing renewal thus comes at an exciting and challenging time of immense opportunity for implementation of the NIH roadmap for diabetes. The new DERC will have 58 members, up from 33 in the previous period. Many of the members were recruited through the externally-reviewed DERC Pilot and Feasibility Program which we plan to expand from three to five awards per year at $50,000 each. An Administrative and four Biomedical Cores in Cytometry, Bioresources, Molecular Resources and Clinical and Informatics will be structured around existing expertise and large instrumentation to deliver state-of-the-art technologies to the greatest number of investigators in a cost-effective manner. Each of the Cores will have customized dedicated space in the new building and will interconnect with other UCHSC Core facilities notably in the areas of mouse gene targeting, microarray analyses, proteomics and bioinformatics. The expanded Research Base also addresses the need to include expertise in these areas using collaborators from within UCHSC and its affiliates such as the National Jewish Medical Research Center. Some new equipment is needed to make the DERC Cores fully operational and has been requested as matching funds on the application when exceeding $10,000 in price. Training is an important component of the DERC and ranges from """"""""Bed and Breakfast"""""""" programs in molecular biology and histological procedures to participating in new NIH training grants and K08 awards. DERC members participate in a series of seminars, journal clubs and an annual workshop. Dr. Hutton, Ph.D., and Dr. Eisenbarth, M.D., Ph.D., will provide administrative oversight of the DERC along with Executive and Steering committees of DERC and UCHSC investigators. The External Advisory Board Members, comprised of distinguished investigators in the field of diabetes are appointed to perform periodic site visits to review the DERC scientific goals and progress towards them. The activities of the DERC will be broadly disseminated through a website ( that also serves as the major conduit for the advertising, ordering and billing for Core services that are offered on a discounted fee-for-service basis to DERC members.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Center Core Grants (P30)
Project #
Application #
Study Section
Special Emphasis Panel (ZDK1-GRB-N (J1))
Program Officer
Hyde, James F
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Colorado Denver
Schools of Medicine
United States
Zip Code
Plenter, Robert J; Grazia, Todd J; Coulombe, Marilyne G et al. (2018) Anti-LFA-1 induces CD8 T-cell dependent allograft tolerance and augments suppressor phenotype CD8 cells. Cell Immunol 332:101-110
Liese, Angela D; Ma, Xiaonan; Ma, Xiaoguang et al. (2018) Dietary quality and markers of inflammation: No association in youth with type 1 diabetes. J Diabetes Complications 32:179-184
Kahkoska, Anna R; Shay, Christina M; Couch, Sarah C et al. (2018) Sociodemographic associations of longitudinal adiposity in youth with type 1 diabetes. Pediatr Diabetes 19:1429-1440
Lee-Sherick, Alisa B; Jacobsen, Kristen M; Henry, Curtis J et al. (2018) MERTK inhibition alters the PD-1 axis and promotes anti-leukemia immunity. JCI Insight 3:
Mendoza, Jason A; Haaland, Wren; D'Agostino, Ralph B et al. (2018) Food insecurity is associated with high risk glycemic control and higher health care utilization among youth and young adults with type 1 diabetes. Diabetes Res Clin Pract 138:128-137
Frohnert, Brigitte I; Laimighofer, Michael; Krumsiek, Jan et al. (2018) Prediction of type 1 diabetes using a genetic risk model in the Diabetes Autoimmunity Study in the Young. Pediatr Diabetes 19:277-283
Shah, V N; Sippl, R; Joshee, P et al. (2018) Trabecular bone quality is lower in adults with type 1 diabetes and is negatively associated with insulin resistance. Osteoporos Int 29:733-739
Pinto, Cathy A; Stafford, Jeanette M; Wang, Tongtong et al. (2018) Changes in diabetes medication regimens and glycemic control in adolescents and young adults with youth-onset type 2 diabetes: The SEARCH for diabetes in youth study. Pediatr Diabetes :
Jensen, Thomas; Bjornstad, Petter; Johnson, Richard J et al. (2018) Copeptin and Estimated Insulin Sensitivity in Adults With and Without Type 1 Diabetes: The CACTI Study. Can J Diabetes :
Agarwal, S; Raymond, J K; Isom, S et al. (2018) Transfer from paediatric to adult care for young adults with Type 2 diabetes: the SEARCH for Diabetes in Youth Study. Diabet Med 35:504-512

Showing the most recent 10 out of 480 publications